COMP <GO>
GRAL vs JNJ // FREE CASH FLOW YIELD
GRAIL Inc. Common Stock (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: GRAL 4
— JNJ 9
▲ FREE CASH FLOW YIELD LEADER: JNJ
LAST: $143.43 (-9.75%) • MKT CAP: $7.10B
fcf-yield
-4.23%
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
fcf-yield
2.97%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GRAL VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GRAL | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 67.90% | -26.90 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -18.00% | 25.50% | -43.50 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | -4.23% | 2.97% | -7.20 | JNJ | /fcf-yield <GO> |
| Operating Margin | -60.00% | 34.70% | -94.70 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 28.50% | -88.50 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 17.20% | 6.00% | +11.20 | GRAL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.26 | 5.59 | +1.67 | GRAL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 7.20% | -0.30 | GRAL | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.1 | 60.4 | -3.27 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.00 | 1.08 | -0.08 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.0x | 23.0x | -1.00 | GRAL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.10B | $662.49B | -$655.39B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GRAL REV | JNJ REV | GRAL GROSS % | JNJ GROSS % | GRAL FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $147.2M | $94.19B | 44.0% | 67.9% | -$299.9M | $19.70B |
| FY 2024 | $125.6M | $88.82B | 44.0% | 69.1% | -$582.4M | $19.84B |
| FY 2023 | $93.1M | $85.16B | 44.0% | 44.0% | -$600.0M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GRAL // BETA 1.00
JNJ // BETA 1.08